Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Reports Q4 Revenue Increase

SAN FRANCISCO, Jan. 28 - Illumina today reported increased revenue for the fourth quarter of 2002.

 

The company said its total revenue was $3.9 million in the fourth quarter which ended December 29, up from $800,000 in the same quarter of 2001. Total revenue for the 2002 year was $10 million, compared to $2.5 million in 2001, according to the company.

 

Illumina reported a net loss of $7.6 million, or $.24 per share, in the fourth quarter 2002 compared to a net loss of $8.2 million, or $.27 per share, in the year-ago period. Total net loss for 2002 was $40.3 million, or $1.31 per share, compared to a net loss of $24.8 million, or $.83 per share, in 2001.

 

R&D spending for the fourth quarter 2002 was $6.3 million compared to $6.1 million in the same period a year ago. Total R&D spending for 2002 was $26.8 million compared to $20.7 million in 2001.

 

Illumina also reported $66.3 million in cash and investments at the end of December 2002.

 

Click here for more information.

 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.